Abstract
Influenza vaccination is the best measure available to prevent seasonal influenza infection. The majority of studies on vaccine effectiveness in the 2015/16 season conducted in the European I-MOVE+ Project, show that a match between the circulating influenza strains in the general public and those included in the vaccine for the Northern Hemisphere was low to moderate. As part of I-MOVE+, Poland has implemented a case control negative study design and molecular biology methods, such as real time RT-PCR, to assess the vaccine match and effectiveness. The research described herein consisted of two major influenza vaccine effectiveness investigations conducted in Poland in the 2015/16 season. The general practice part of the study included 228 cases consisting of 159 type A, 65 type B, and 4 coinfections (types A + B), and 312 negative control cases. The hospital study part included 26 cases consisting of 21 type A, 2 type B, and 3 coinfections, and 13 negative control cases. The data were collected from patients of all ages recruited by 46 volunteering doctors in 15 Poland’s provinces and three hospitals, respectively. In both study parts, only were seven patients and 12 control subjects vaccinated. Low vaccine coverage, a major limitation of the Polish study, makes the calculation of vaccine effectiveness for the Polish population hardly applicable statistically. Despite the crudeness of data, they were included into the common European analysis. The overall vaccine effectiveness amounted to 21.0% (95% CI: 74–122). It was somehow better for type B virus: 53.9% (95% CI: 47–87) and type A virus: 23.6% (95% CI: 83–185). A larger sample size is needed to achieve a desired interpretation of results on influenza vaccine effectiveness in Poland.
References
Blank P, Schwenkglenks M, Szucs TD (2012) The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly. Hum Vaccin Immunother 8(3):328–335
Centers for Disease Control and Prevention (2013) Seasonal influenza (flu). https://www.cdc.gov/flu/pastseasons/1314season.htm. Accessed on 16 May 2017
Council of the European Communities (2009) Proposal for a Council Recommendation on Seasonal Influenza Vaccination. https://ec.europa.eu/health/ph_threats/com/Influenza/docs/seasonflu_rec2009_en.pdf. Accessed on 8 May 2017
Council of the European Union. State of play on implementation of the Council Recommendation of 22 December 2009 on seasonal influenza
ECDC (2016) European Centre for Disease Prevention and Control. Seasonal Influenza Vaccine Effectiveness, 2005–2016. https://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm. Accessed on 9 May 2017
Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB, Centers for Disease Control and Prevention (2014) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) – United States, 2014–15 influenza season. MMWR Morb Mortal Wkly Rep 63(32):691–697
Hallmann-Szelińska E, Bednarska K, Korczyńska M, Paradowska-Stankiewicz I, Brydak LB (2016) Virological characteristics of the 2014/2015 influenza season based on molecular analysis of biological material derived from I-MOVE study. Adv Exp Med Biol 921:81–86
I-Move in Europe (2016) https://sites.google.com/site/epiflu/. Accessed on 9 May 2017
Kissling E, Valenciano M (2016) Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study. Euro Surveill 21(6). doi:10.2807/1560-7917.ES.2016.21.6.30134
Pebody R, Warburton F, Ellis J, Andrews N, Potts A et al (2016) Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Euro Surveill 21(38). doi:10.2807/1560-7917.ES.2016.21.38.30348
Rizzo C, Bella A, Alfonsi V, Puzelli S, Palmieri AP et al (2016) Influenza vaccine effectiveness in Italy: age, subtype-specific and vaccine type estimates 2014/15 season. Vaccine 34(37):3102–3108
Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A et al (2016) Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Euro Surveill 21(7). doi:10.2807/1560-7917.ES.2016.21.7.30139
Acknowledgements
We are grateful to the EpiConcept and ECDC for giving an opportunity to carrying out the study in Poland. Supported in part by the I-MOVE+ Project and H2020 funds.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Paradowska-Stankiewicz, I., Korczyńska, M.R., Cieślak, K., Kowalczyk, D., Szymański, K., Brydak, L.B. (2017). Vaccine Effectiveness against Influenza in 2015/16 in Hospital and Ambulatory Medical Care Facilities: Polish Results of the European I-MOVE+ Multicenter Study. In: Pokorski, M. (eds) Pulmonary Disorders and Therapy. Advances in Experimental Medicine and Biology(), vol 1023. Springer, Cham. https://doi.org/10.1007/5584_2017_69
Download citation
DOI: https://doi.org/10.1007/5584_2017_69
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73702-7
Online ISBN: 978-3-319-73703-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)